Rudolph Emile Tanzi
Chairman of The Scientific Advisory BoardDr. Rudolph Emile Tanzi, also known as Rudy, serves as the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School. At Massachusetts General Hospital, he serves as Director of the Genetics and Aging Research Unit, Director of the McCance Center for Brain Health, and Co-Director of the MassGeneral Institute for Neurodegeneration. He serves as Chief Scientific Advisor and Member of the Research & Development Advisory Board at Alterity Therapeutics Limited, which he joined on March 22, 2007. He serves as Member of the Scientific Advisory Board at Niagen Bioscience, Inc. since June 27, 2017. He serves as Member of the Scientific Advisory Board at Smart Biosciences, Inc. He is Co-Founder of NeuroGenetic Pharmaceuticals, Inc., which he joined in 2009. He serves as Member of the Advisory Board at InteraXon Inc. He serves as Chairman of Scientific Advisors of AZTherapies, Inc. He serves as Chairman of The Scientific Advisory Board of Amylyx Pharmaceuticals, Inc. He is Co-founder of Cognitive Clarity Inc. and also serves as Chief Scientific Advisor. He serves as Member of the Scientific Advisory Board of Dolby Family Ventures, L.P. He serves as Chairman of the Neurodegenerative Scientific & Clinical Advisory Board of Cognos Therapeutics, Inc. since October 2024. He serves as Member of the Scientific Advisory Board of ROKIT Healthcare Inc. He is Co-Founder of DRADS Capital. He is Co-Founder of REACT Neuro. He is Co-Founder of MarvelBiome, Inc. and also serves as Director. He serves as Chairman of the Scientific Advisory Board of ADvantage Therapeutics Inc. His prior experience includes serving as Co-Chairman of the Scientific Advisory Board at Jupiter Neurosciences, Inc. from November 1, 2019 to September 2025. At ProMIS Neurosciences, Inc., he served as Chair of the Scientific Advisory Board from May 12, 2021 to March 2024 and as Member of the Scientific Advisory Board from December 17, 2018 to May 12, 2021. He served as Member of the Scientific Advisory Board at Annovis Bio, Inc. from January 24, 2017 to March 2022. He was Member of the Scientific Advisory Board at Vivoryon Therapeutics N.V., which he joined on May 6, 2016. He was Member of the Scientific Advisory Board of Genomind, Inc., which he joined on September 13, 2012. He was Co-Founder of TorreyPines Therapeutics, Inc., which he joined in 2000. He also served as Member of the Scientific Advisory Board at Cognoptix Inc., as a Member of Advisor of Cerevance, LLC, and as a Scientific Advisor of Pathway Genomics Corporation. Dr. Tanzi discovered numerous Alzheimer’s disease genes, including the first three early-onset Alzheimer’s genes, as well as several other brain disease genes and directs the Alzheimer’s Genome Project™. He has started numerous biotech companies to develop novel therapies for Alzheimer’s disease. He was named as one of the Top 1% Highly Cited Researchers Global and was named to the TIME100 List of Most Influential People in the World. He has co-authored numerous research publications with numerous citations and is a New York Times bestselling author of “Decoding Darkness”, “Super Brain”, “Super Genes”, and “The Healing Self”. Dr. Tanzi has made numerous network TV appearances and hosted several TV shows on PBS. He has a B.S. in Microbiology from the University of Rochester in 1980, a B.A. in History from the University of Rochester in 1980, and a Ph.D. in Neurobiology from Harvard Medical School in 1990.
Positions
- Company NameAmylyx Pharmaceuticals, Inc.Stock CodeAMLXPositionChairman of The Scientific Advisory BoardColleagues
- JBJoshua B. CohenCo-Founder, Co-CEO & Director
- GMGeorge Mclean MilneIndependent Chairman of the Board
- JBJustin B. KleeCo-CEO & Director
- JMJames M. FratesChief Financial Officer
- CLCamille L. BedrosianChief Medical Officer
- THTom HolmesChief Technical Operations Officer
- PRPaul R. FonteyneIndependent Director
- Company NameAlterity Therapeutics LimitedStock CodeATHEPositionChief Scientific Advisor and Member of Research & Development Advisory BoardColleagues
- DADavid A. StamlerCEO, MD & Director
- JBJulian BabarczyIndependent Non-Executive Chair
- AMAbby Macnish NivenCFO & Company Secretary
- RERudolph Emile TanziChief Scientific Advisor and Member of Research & Development Advisory Board
- SDSteven D. TargumChief Medical Advisor
- RCRobert ChernyHead of Research
- PAPeter Ashley MarksNon-Executive Independent Director
- ISIra ShoulsonChairman of Research & Development Advisory Board
